Nanotechnology, which has existed as a distinct field of study since the 1980s, encompasses the use of nanomaterials not only in electronics and catalysis, but also in biomedical research, such as drug delivery, bioimaging, biomedical diagnosis, and tissue engineering. The application of nanoscience in pharmacy and the manufacturing of drug delivery, diagnostic, imaging, and biosensor devices has the potential to have a significant impact on human health. Nanocarriers can increase blood circulation time by preventing opsonization and uptake by phagocytes, which improves therapeutic pharmacokinetics and biodistribution. Better bio-distribution of active compounds, protection against degradation, passage, targeting, increased drug attachment, expulsion, and communication with biological barriers are all benefits of incorporating therapeutic molecules in nanocarriers.
- Nanoparticles: Innovations and Trends
- Nanomedicine and Biomedical Applications
- Nanoparticulate Drug Delivery Systems
- Nanoparticle Delivery of Non-Coding RNAs
- Nanoparticle Fabrication
- Big Data to Help Nanotechnology
- Clinical Translation of Nanotechnology
- Nanoparticles for Immuno-Oncology and Screening
John K Maesaka
NYU Langone Hospital Long Island, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Saad Tayyab
UCSI University, Malaysia
Vladlen Slepak
University of Miami, United States
Andreas M Papas
East Tennessee State University, United States
Huiqin Yang
ICON Clinical Research Ltd, United Kingdom
Alessandro Gallo
Springer Healthcare, Italy
Gurpreet Singh
IQVIA, United Kingdom
Maria Cristina Gamberini
University of Modena e Reggio Emilia, ItalySubmit your abstract Today
Title : Liver biopsy handling of Metabolic-Associated Fatty Liver Disease (MAFLD): The children's hospital of eastern Ontario grossing protocol
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Haptoglobin-Related Protein Without Signal Peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States
Title : Enabling knowledge-driven integration and interoperability in intelligent and ethical transformed health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets. Discovery of agonists and antagonists of OR51E1, an understudied G Protein-Coupled Receptor
Vladlen Slepak, University of Miami, United States
Title : Revolutionizing healthcare and pharma: Artificial intelligence-powered scientific communications and medical writing
Alessandro Gallo, Springer Healthcare, Italy
Title : Understanding drug transport in plasma: the role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up via biodesign-driven biotech and upgraded biomarketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Cell viability assays under radiofrequency application modulated by nanomaterials
Paulo C De Morais, Catholic University of Brasilia, Brazil
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Biosimilars - The current progress
Miroslav Radenkovic, University of Belgrade, Serbia